Mechanism of curcumin resisting esophageal cancer

doi:10.3760/cma.j.issn.1673-422X.2016.05.015

Abstract

Tian Ruonan,Sun Jianjing, Zhang Linxi. Mechanism of curcumin resisting esophageal cancer[J]. Journal of International Oncology, 2016, 43(5): 379-381.

［1］ Liao S, Xia J, Chen Z, et al. Inhibitory effect of curcumin on oral carcinoma CAL27 cells via suppression of Notch1 and NFκB signaling pathways［J］. J Cell Biochem, 2011, 112(4): 1055-1065. DOI: 10.1002/jcb.23019. ［2］ Ashworth T, Roy AL. Phase specific functions of the transcription factor TFⅡⅠ during cell cycle［J］. Cell Cycle, 2009, 8(4): 596-605. ［3］ Mendelson J, Song S, Li Y, et al. Dysfunctional transforming growth factorβ signaling with constitutively active Notch signaling in Barrett′s esophageal adenocarcinoma［J］. Cancer, 2011, 117(16): 3691-3702. DOI: 10.1002/cncr.25861. ［4］ Peters JH, Avisar N. The molecular pathogenesis of Barrett′s esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia［J］. J Gastrointest Surg, 2010, 14 Suppl 1: S81-87. DOI: 10.1007/s1160500910117. ［5］ Masuda S. Dysfunctional transforming growth factorβ signaling with constitutively active notch signaling in Barrett′s esophageal adenocarcinoma［J］. Cancer, 2012, 118(7): 1956-1957. DOI: 10.1002/cncr.26444. ［6］ Subramaniam D, Ponnurangam S, Ramamoorthy P, et al. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling［J］. PLoS One, 2012, 7(2): e30590. DOI: 10.1371/journal.pone.0030590. ［7］ Tian F, Fan T, Zhang Y, et al. Curcumin potentiates the antitumor effects of 5FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NFκB signaling pathway in vitro and in vivo［J］. Acta BiochimBiophys Sin(Shanghai), 2012, 44(10): 847-855. ［8］ Hanahan D,Weinberg RA.Hallmarks of cancer: the next generation［J］. Cell, 2011, 144(5): 646-674. DOI: 10.1016/j.cell.2011.02.013. ［9］ Shehzad A, LeeJ, Lee YS. Curcumin in various cancers［J］. Biofactors, 2013, 39(1): 56-68. DOI: 10.1002/biof.1068. ［10］ Stasinopoulos I, Shah T, Penet MF, et al. Cox2 in cancer: Gordian knot or Achilles heel?［J］. Front Pharmacol, 2013, 4: 34. DOI: 10.3389/fphar.2013.00034. ［11］ Park J, Conteas CN. Anticarcinogenic properties of curcumin on colorectal cancer［J］. World J Gastrointe Oncol, 2010, 2(4): 169-176. DOI: 10.4251/wjgo.v2.i4.169. ［12］ Ye F, Zhang GH, Guan BX, et al. Suppression of esophageal cancer cell growth using curcumin, ()epigallocatechin3gallate and lovastatin［J］. World J Gastroenterol, 2012, 18(2): 126-135. DOI: 10.3748/wjg.v18.i2.126. ［13］ Xu XC. Risk factors and gene expression in esophageal cancer［J］. Methods Mol Biol, 2009, 471: 335-360. DOI: 10.1007/9781597454162_17. ［14］ Mukherjee T, Kumar A, Mathur M, et al. Ets1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma［J］. J Cancer Res Clin Oncol, 2003, 129(7): 430-436. ［15］ Xiao X, Prasadan K, Guo P, et al.Pancreatic duct cells as a source of VEGF in mice［J］. Diabetologia, 2014, 57(5): 991-1000. DOI: 10.1007/s001250143179y. ［16］ Xiao X, Guo P, Chen Z, et al.Hypoglycemia reduces vascular endothelial growth factor a production by pancreatic beta cells as a regulator of beta cell mass［J］. J Biol Chem, 2013, 288(12): 8636-8646. DOI: 10.1074/jbc.M112.422949. ［17］武志, 潘晓玲, 仲洁. MMP2和MMP9在食管癌中表达的研究［J］. 国际肿瘤学杂志, 2013, 40(9)： 708-711. DOI: 10.3760/cma.j.issn.1673422X.2013.09.022. ［18］ Chen Y, Jiang T, Mao A, et al. Esophageal cancer stem cells express PLGF to increasecancer invasion through MMP9 activation［J］. Tumor Biol, 2014, 35(12): 12749-12755. DOI: 10.1007/s132770142601x. ［19］ Colombo E, Alcalay M, Pelicci PG. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases［J］. Oncogene, 2011, 30(23): 2595-2609. DOI: 10.1038/onc.2010.646. ［20］ Chiarella S, De Cola A, Scaglione GL, et al. Nucleophosmin mutations alter its nucleolar localization by impairing Gquadruplex binding at ribosomal DNA［J］. Nucleic Acids Res, 2013, 41(5): 3228-3239. DOI: 10.1093/nar/gkt001. ［21］ Shi SL, Liang Y, Li QF, et al. Localization of nucleophosmin in nuclear matrix and changes in its expression during the differentiation of human neuroblastoma induced by retinoic acid［J］. J Cell Biochem, 2010, 111(1): 67-74. DOI: 10.1002/jcb.22663. ［22］ Weng CH, Yung BY, Weng JJ, et al. Involvement of nucleophosmin/B23 in the cellular response to curcumin［J］. J Nutr Biochem, 2011, 22(1): 46-52. DOI: 10.1016/j.jnutbio.2009.11.010.

[1]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[2]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[3]	Wan Fang, Yang Gang, Li Rui, Wan Qijing. Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer [J]. Journal of International Oncology, 2024, 51(4): 204-209.
[4]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[5]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer. Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition） [J]. Journal of International Oncology, 2023, 50(7): 385-397.
[6]	Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong. Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2023, 50(2): 76-81.
[7]	Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng. Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy [J]. Journal of International Oncology, 2023, 50(12): 745-750.
[8]	Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei. Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(8): 464-472.
[9]	Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian. Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN₊ esophageal squamous cell carcinoma patients [J]. Journal of International Oncology, 2022, 49(6): 334-339.
[10]	Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong. Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer [J]. Journal of International Oncology, 2022, 49(4): 199-205.
[11]	Zhou Jianfeng, Wang Tiejun. Targeted therapy and immunotherapy of esophageal cancer [J]. Journal of International Oncology, 2022, 49(4): 237-242.
[12]	Liu Jia, Ge Xiaolin, Di Xiaoke, Shi Yujing, Zeng Yuting. Efficacy analysis of Xiyanping injection on prevention of radioactive esophagitis [J]. Journal of International Oncology, 2022, 49(3): 146-150.
[13]	Zhang Junpeng, Yu Yanyan, Li Baosheng. Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(3): 185-189.
[14]	Geng Hui, Hu Fengchao, Lu Hongchao, Guo Jungang, Qi Zengping. Effects of TPF regimen and IMRT on immune function and survival prognosis of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2022, 49(2): 84-88.
[15]	Guo Xinwei, Zhang Han, Ye Hongxun, Liu Yangchen, Ji Shengjun, Zhou Shaobing, Zhou Juying. Influence of preoperative Naples prognostic score on prognosis of patients with thoracic esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(2): 89-94.

Mechanism of curcumin resisting esophageal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments